Connect with us

Heartland

FDA's 2nd CBD Hearing Won't Be the One the Industry Wants

Republished by Plato

Published

on

WASHINGTON — A public hearing next month by U.S. Food and Drug Administration (FDA) won’t be the resolution of regulation of ingestible CBD products that many industry watchers had hoped.

The FDA announced in September that it would hold the public meeting on cannabidiol (CBD) and other cannabinoids to discuss the differing way these ingredients effect each gender.

The Nov. 19 event titled CBD and Other Cannabinoids: Sex and Gender Difference in Use and Responses will be hosted by the FDA’s Office of Women’s Health and is described as a “multidisciplinary scientific conference.”

Intended topics of discussion include:

  • Sex differences in the effects of CBD and other cannabinoids
  • Use of CBD and other cannabinoids in pregnancy
  • Government agency perspectives on CBD research

Jonathan Havens, a partner in Washington, D.C., and Baltimore-based Saul Ewing Arnstein & Lehr LLP, took note of the specificity of the November meeting announcement and expressed caution for anyone hoping the event would provide insight into future ingestible CBD product regulations.

“It sounds to me like this is a listening session for researchers, educators, clinicians and patients to talk to FDA about the studies they’ve undertaken, the data they’ve reviewed, the patients they’ve treated, their personal experience, and the like,” Havens told CSP Daily News. “While the conference will be interesting and suggests FDA continues to be focused on cannabis and CBD, I don’t expect that we’ll be able to glean additional insight into how FDA might regulate ingestible CBD products.”

Havens, a former regulatory counsel at the FDA, took note of a statement the agency made about why it was seeking to address these questions of sex and gender.

“Conditions for which CBD is often marketed, such as chronic pain, anxiety, depression and sleep disturbances, are more prevalent in women than men,” the agency said in the event announcement. “Therefore, consideration of issues pertaining to the safety of CBD products may be particularly important to address in women.”

“Beyond the conclusions FDA has drawn about these ailments being more prevalent in women than men, it’s also interesting to note that at least some of them are considered by FDA to be medical conditions,” Havens said. “This suggests to me that the conference will focus mostly if not exclusively on drug products as opposed to dietary supplements.”

The drug positioning and streamlined agenda marks a stark difference between the first CBD meeting the FDA held in May 2019. While the substance’s therapeutic potential was certainly discussed during the agency’s first-ever public hearing on CBD, the agency also heard from manufacturers, retailers, the agricultural industry and state and local regulators.

“Given the wide-ranging feedback FDA sought at its hearing last May, we were able to better understand the agency’s policy questions and priorities,” Havens said.  “The November hearing is being billed as a scientific conference, one that will likely be research- and data-driven, so I don’t expect we’ll have a better understanding of FDA’s thinking on consumer (i.e., non-drug) CBD products after it.”

A research note by New York-based Cowen Washington Research Group agreed with this assessment, noting the meeting is “unlikely to provide a definitive conclusion on how the agency will regulate the CBD industry” but it “could provide important clues. The meeting suggests that the FDA is at least still moving the ball on CBD and it could provide an update on the agency’s perspectives on CBD research and evaluation.”

Many manufacturers, retailers and consumers are anxious for the FDA to address the marketing and sale of edible CBD products as they believe those products will become the most popular segment of the category.

Want breaking news at your fingertips?

Get today’s need-to-know convenience industry intelligence. Sign up to receive texts from CSP on news and insights that matter to your brand.

Source: https://www.google.com/url?rct=j&sa=t&url=https://www.cspdailynews.com/cbdhemp/fdas-2nd-cbd-hearing-wont-be-one-industry-wants&ct=ga&cd=CAIyGmFhNDVjMDg0ZjNlMjdiMmY6Y29tOmVuOlVT&usg=AFQjCNHro56LcwbjKPUa55i8D84xrekf_g

Heartland

Growth of Cannabidiol Oil (CBD Oil) Market Size Report Till 2025

Republished by Plato

Published

on

The Global Cannabidiol Oil (CBD Oil) Market covers explicit information regarding the development rate, market estimates, drivers, limitations, future … Source:

Continue Reading

Heartland

Hemp Seed Market Explosive Factors of Revenue by Major Manufacturers |Hempco Inc, Ecofibre …

Republished by Plato

Published

on

Hemp Seed Market research report is the high quality report having in-depth market research studies. This market report provides best solutions for … Source:

Continue Reading

Heartland

CBD Oil Market 2021 Global Industry Size, Reviews, Segments, Revenue, and Forecast to 2027

Republished by Plato

Published

on

Fort Collins, Colorado: The most recently published CBD Oil Market report provides a critical assessment of key growth dynamics, emerging pathways, … Source:

Continue Reading
Heartland1 day ago

CBD Vape Oil Market 2021: Global Trends, Business Overview, Challenges, Opportunities …

Heartland4 days ago

Uncategorized5 days ago

What CBD Oil is Right For Me?

Heartland4 days ago

Heartland3 days ago

Heartland4 days ago

Registration opens for consumable hemp manufacturers and retailers

Heartland4 days ago

CBD Oil for Beginners

Heartland4 days ago

CBP Can't Block Parts Imports, Hemp Machinery Co. Says

Heartland3 days ago

8 of the best cannabis gummies to try right now

Heartland2 days ago

National Hemp Association Awards First Recipients of Social Equity Conscious Business (SECB …

Heartland2 days ago

Industrial Hemp in Automotive Market Estimated Forecast Analysis 2021-2030

Heartland5 days ago

Interactions between CBD and hormonal contraception

Metal5 days ago

Pakistani CRC and HDG producers raise prices on higher input costs

Heartland4 days ago

CBD Skincare Products Are Popping Up Everywhere — But Do They Actually Work?

Heartland4 days ago

Sunnyvale Labs CBD Gummies — Instant Pain Relief Hemp Gummies!

Heartland4 days ago

Heartland3 days ago

Heartland4 days ago

Material4 days ago

IMC microstructure modification and mechanical reinforcement of Sn–Ag–Cu/Cu microelectronic joints through an advanced surface finish technique

Heartland4 days ago

Hemp Is Creating an EcoRevolution

Heartland4 days ago

CBD to combat physcoactive properties in THC

Material2 days ago

Microstructure, characterization of interfacial phases and mechanical properties of high Nb–TiAl/Al2O3 joints brazed by novel Nb particle-reinforced Ag–Cu filler alloy

Heartland5 days ago

12 Ways CBD products can Improve your Health and Wellbeing – 2021 Review

Heartland5 days ago

Former Eaze CEO Pleads Guilty In Bank Fraud Case

Heartland5 days ago

Material4 days ago

A new approach of predicting dynamic recrystallization using directly a flow stress model and its application to medium Mn steel

Heartland4 days ago

Acreage Holdings to Sell Florida Cannabis Operations to Red White & Bloom for $60 Million

Heartland4 days ago

Uncategorized3 days ago

The Daily Hit: The February 25th, 2021

Heartland2 days ago

Drew Carey CBD – How Does It Work For Body Pain

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America